Cefepime Hydrochloride for injection

On January 28, Shanxi provincial centralized bidding procurement network of medical devices issued the notice of Shanxi Province on publicizing the cancellation of qualification of cefepime hydrochloride for injection in Shanghai Squibb Pharmaceutical Co., Ltd of China and the United States in 2019 (hereinafter referred to as the notice) According to the notice, cefepime for injection (1g and 0.5g) tendered by Shanghai Shiguibao Pharmaceutical Co., Ltd of China and the United States is a non essential drug with small historical purchase volume, and has been listed in the classified purchase catalogue of public medical institutions in Shanxi Province Now Squibb pharmaceutical has applied for the cancellation of the network hanging in Shanxi Province due to the shortage of raw materials, and promised to cancel the network hanging and supply nationwide The details are as follows: all medical institutions and drug distributors: cefepime for injection (1g and 0.5g) tendered by Shanghai Shiguibao Pharmaceutical Co., Ltd of China and the United States is a non essential drug with small historical purchase volume, and has been listed in the classified purchase catalogue of public medical institutions in our province Now the enterprise has put forward that the production of the product has been stopped due to the shortage of raw materials, applied for the cancellation of the network hanging in our province, and promised to cancel the network hanging and supply nationwide In accordance with Article 3 (procurement cycle and withdrawal of online qualification management) of document jwyzf [2018] No 2 of the original notice of Shanxi health and Family Planning Commission on doing well in the procurement of online negotiated drugs for public medical institutions in 2018, it is proposed to cancel its online qualification in our province It is hereby publicized: 1 From January 28 to February 1, 2019 at 17:00 2、 In case of any objection to the contents of the publicity, the authorized person shall bring the power of attorney of the legal person of the production (operation) enterprise within the publicity period, and submit the application (investment) materials to the centralized bidding and purchasing center of Shanxi Province, which shall not be accepted after the expiration of the time limit 3、 After the end of the publicity period, if no relevant application (application) materials are received, the qualification of relevant drugs to be online will be cancelled directly in the platform, and no further notice will be issued Contact person: Hao Rui address: room 1020, ten / F, Terry Int'L Commercial Affairs Hotel, No 7, Changfeng street, Xiaodian District, Taiyuan City, Shanxi province Tel: 0351-3580669